23andMe Holding Co. - Rasio rega marang prakiraan pendapatan ME
23andMe Holding Co. combines retail DNA testing with B2B pharmaceutical partnerships to minimize risk. The forward P/S value on the GURU.Markets chart illustrates the current trend, where the metric is fixed at 0.10. The company generates revenue through subscriptions and the sale of genetic kits, while focusing on drug R&D and the stabilization of its software.
Rincian metrik komprehensif lan analitis 23andme.com (ME)
- rega saiki lan proyeksi nilai saham:
- rincian nilai pasar emiten:
- indikator nilai buku ekuitas:
- data tingkat utang lan likuiditas finansial:
Total Utang marang Modal 23andMe Holding Co.|ME - Koefisien utang jangka dawa marang modal|Utang jangka cendhak marang ekuitas 23andMe Inc|ME - Utang kumulatif perusahaan|Rasio utang marang kapitalisasi buku 23andMe Holding Co.|ME - Utang jangka dawa perusahaan|Utang jangka cendhak perusahaan 23andMe|Rasio cepet 23andme.com
- rincian asil keuangan lan kelipatan valuasi:
ME - Asil keuangan resik|Bathi sing dikarepake 23andMe Holding Co.|ME - Pangali rega marang bathi|Pangali Forward P/E 23andMe Inc|ME - Rasio rega marang wutah bathi resik|Rasio nilai perusahaan marang bathi sadurunge bunga, pajeg, lan panyusutan 23andMe Holding Co|ME - Pendapatan sadurunge ngurangi bunga, pajak, lan amortisasi|Bathi resik saben saham (EPS TTM) 23andMe|ME - Bathi resik saben saham sajrone 12 wulan pungkasan|Wutah bathi saben saham taun-ka-taun sajrone rolas wulan pungkasan 23andme.com|ME - Kacepetan wutah bathi saben saham ing taun lumaku|Prakiraan wutah bathi saben saham kanggo taun ngarep 23andMe Holding Co.
- rincian pendapatan lan dodolan:
Analisis wiwitan perusahaan:ME (23andMe Inc.)
Investing in 23andMe Holding Co. (ME) requires a rigorous filter of fundamental metrics to verify the asset's market value. The business's forward P/S ratio compares current market capitalization with expected sales volumes, allowing for an assessment of the company's valuation adequacy against a systemic decline in demand for genetic tests and a loss of customer trust, which is critical for determining the viability of the issuer's capital.
Karo sapa 23andMe Holding Co. saingan
Multiplikator Forward P/S A (agilent.com)|Quest Corp (DGX) - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|ILMN - Rasio rega marang prakiraan pendapatan|EXAS - Multiplikator Forward P/S|RVTY (Revvity) - Multiplikator forward rega marang pendapatan|Bio-Rad - Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan anbio.com|Multiplikator Forward P/S Sotera Health Company|Rasio rega marang prakiraan pendapatan QuidelOrtho (QDEL)|OPK - Rasio kapitalisasi pasar marang pendapatan mangsa ngarep|caredx.com - Multiplikator forward rega marang pendapatan|Rasio kapitalisasi marang dodolan sing dikarepake Maravai LifeSciences Corp (MRVI)|FLGT: Multiplikator forward rega marang pendapatan|Rega forward marang dodolan LAB (Fluidigm)|Cytek Biosciences Inc (CTKB) - Rasio rega marang prakiraan pendapatan|OSUR: Rasio rega marang pendapatan sing dikarepake|Multiplikator forward rega marang pendapatan XGN|MDXH: Rega forward marang dodolan|Rasio rega marang prakiraan pendapatan Lucid Diagnostics Inc. (LUCD)|Rasio rega marang prakiraan pendapatan PRE (Prenetics Global Limited)|Multiplikator Forward P/S IMDX (Insight Molecular Diagnostics Inc)|Rasio rega marang pendapatan sing dikarepake TRIB (Trinity Biotech Corp)|PRPH - Rasio rega marang prakiraan pendapatan|Ainos (AIMD) - Multiplikator forward rega marang pendapatan|CoDx (CODX) - Rasio rega marang prakiraan pendapatan|HSCS (Heart Test Labs) - Rasio rega marang prakiraan pendapatan|BMRA (Biomerica, Inc.) - Multiplikator Forward P/S|CDIO (Cardio Diagnostics) - Rasio rega marang pendapatan sing dikarepake|Rasio rega marang prakiraan pendapatan Onconetix Corp (ONCO)|VRAX (Virax Biolabs Group Limited) - Rega forward marang dodolan|Multiplikator Forward P/S BJDX (Bluejay Diagnostics Corp)|Aspira Women's Health - Rasio rega marang prakiraan pendapatan|AXDX - Rasio rega marang prakiraan pendapatan|Prakiraan rega marang pendapatan Centogene NV (CNTG)|ENZ (Enzo Biochem) - Multiplikator forward rega marang pendapatan|fresh2.co (FRES) - Multiplikator Forward P/S|Rasio rega marang prakiraan pendapatan Genetic Technologies Limited|Multiplikator Forward P/S Psychemedics Inc
